Ngosizo lwe-Bioendo, umkhiqizo wokugoma wokuqala waseChina oqinisekisiwe we-GMP ogunyazwe ukusetshenziswa yi-EU futhi wethulwa emakethe ye-EU.

Ekupheleni kuka-2019, ubhubhane olusha lomqhele lwalushubile.NgoZibandlela wezi-2020, umuthi wokugomela igciwane lomqhele owawungasebenzi owenziwe futhi okhiqizwa inkampani eyaziwa kakhulu ye-biopharmaceutical wawusebenza kahle ngama-86% ekulweni nokutheleleka ngegciwane, futhi izinga lokuguqulwa kwe-antibody elingasebenzi lalingu-99%, elingase livikeleke ngo-100%.amacala anzima futhi aqinile e-COVID-19.Umuthi wokugoma uthole ukugunyazwa kokusetshenziswa kwezimo eziphuthumayo ezweni ngoSepthemba ukuvikela abasebenzi bezokwelapha abalwa phambili kwalolu bhubhane.I-ejensi kazwelonke yokugunyazwa kwezidakamizwa kanye ne-ejensi elawulayo ikhiphe ngokusemthethweni isitifiketi se-EU GMP somuthi omusha wokugoma ongasebenzi enkampanini ye-biopharmaceutical.Lona umkhiqizo wokuqala wokugoma ogunyazwe ukusetshenziswa e-EU kanye ne-GMP ogunyazwe emlandweni waseShayina, othatha isinyathelo esisha sokuthi umgomo omusha waseChina wokugomela ube umkhiqizo womphakathi womhlaba.Ukuze ubonise ngempela umphumela wokushisa okomile kokushisa kanye nokuchithwa komugqa wokukhiqiza umgomo we-vial, inkampani yethu isebenzisa inqubo yokukhiqiza eyingqayizivele ukwenza ngokwezifiso i-2ml, 3ml kanye nokunye okucacisiwe kohlobo olufanayo lwebhodlela lezitsha ezisetshenziswa ekukhiqizeni i-biopharmaceutical. inkampani.Isikhombi se-Endotoxin esimelana nezinga lokushisa eliphezulu (ukushisa okomile okufakwe inzalo ye-endotoxin inkomba ECV), esixazulula izidingo zokukhiqizwa kwemikhiqizo yokugoma.Inkampani yethu yenze ingxenye yethu ocwaningweni nasekuthuthukisweni komjovo omusha wokugomela umqhele, ukukhiqizwa, ukulawulwa kwekhwalithi, kanye nokutholwa kwe-endotoxin.


Isikhathi sokuthumela: May-30-2019